Analysis of immune related adverse events of pembrolizumab using FAERS database [0.03%]
应用FAERS数据库分析派姆单抗的免疫相关不良反应
Feilong Tan,Li Zhou,Guijiang Huang et al.
Feilong Tan et al.
Objective: This study aims to investigate the risk signals associated with pembrolizumab and provide references for its safe and rational clinical use. Me...
Histopathologic spectrum and clinical management of pharyngeal and laryngeal sarcomas [0.03%]
咽部和喉部肉瘤的组织病理学谱系及临床管理策略
Anna K Stenzl,Carolin Mogler,Amir Bolooki et al.
Anna K Stenzl et al.
Introduction: Sarcomas are rare mesenchymal malignancies (
Hidden Resources for Cancer Patients - Interactions between spirituality, religiosity and selected factors influencing patient's self-care [0.03%]
癌症患者的隐性资源——精神信仰以及选择因素对患者自我照顾的影响之间的相互作用
Sebastian Ruhe,Helmut Orawa,Jutta Huebner et al.
Sebastian Ruhe et al.
Introduction: Religiosity and spirituality (SpR) can be vital in helping people face life's challenges. While Spiritual Care (SpC) is used in palliative care, this study explores effects for cancer patient's self-care (SC...
Long-term survival of node-positive breast cancer with complete nodal response to neoadjuvant chemotherapy treated with sentinel lymph node biopsy alone: A meta-analysis [0.03%]
新辅助化疗完全缓解的淋巴结阳性乳腺癌患者采用哨兵淋巴结活检手术的长期生存效果：一项meta分析研究
Yunfeng Ding,Wanbo Wu,Xiaofeng Ni et al.
Yunfeng Ding et al.
Introduction: There exist concerns regarding the use of sentinel lymph node (SLN) biopsy alone in node-positive breast cancer patients who have a clinical/radiological complete response in the axilla and are negative on h...
Effects of chemotherapy( Anthracyclin, Cyclophosphamide following docetaxel regimen) on sleep, anxiety, depression and quality of life in patients with breast cancer [0.03%]
化疗（多西他赛方案后采用蒽环类和环磷酰胺）对乳腺癌患者睡眠、焦虑、抑郁及生活质量的影响
Suhyun Ju,Youn Joo Jung,Seungju Lee et al.
Suhyun Ju et al.
Introduction Chemotherapy can cause sleep disorders, anxiety, depression, and decreased quality of life (QoL). This study aimed to compare sleep, anxiety, depression, and QoL during chemotherapy in patients with breast cancer to provide app...
Hepatocellular carcinoma with multiple primary malignancy: A Retrospective Study of 106 Cases [0.03%]
多原发癌伴肝细胞癌的临床分析（106例）
Yifei Li,Liuxing Feng,Chundong Lin et al.
Yifei Li et al.
Background: Multiple primary malignancies (MPM) are a rare scenario, particularly in patients with hepatocellular carcinoma (HCC). Research addressing MPM patients with HCC is limited. Therefore, we conducted a retrospect...
A real-world pharmacovigilance analysis for Demethylation drug: findings from the FDA adverse event reporting database [0.03%]
去甲基药物的现实世界药品不良反应监测分析：来至美国食品药品监督管理局不良事件上报数据库的发现
Shupeng Chen,Jie Liu,Yao Gao et al.
Shupeng Chen et al.
Introduction: The real-world safety profiles of the demethylating agents Azacitidine and Decitabine remain inadequately characterized despite their widespread clinical use. Both drugs are extensively employed for the trea...
Significance of TYMS Polymorphism rs3819102 as a Prognostic Marker for Nonsmoking Lung Cancer Patients of the Han Ethnicity in China [0.03%]
TYMS基因多态性rs3819102对中国汉族非吸烟肺癌患者预后的预测价值分析
Wei Du,Chang Xu,Zhiyuan Cheng et al.
Wei Du et al.
Introduction: With high incidence and mortality rates, lung cancer is now one of the most common cancers in the world. The 5-year survival rate of lung cancer patients is very low, and predicting the prognosis of lung can...
High expression of tetraspanin CD63 predicts poor prognosis in esophageal squamous cell carcinoma [0.03%]
四跨膜蛋白CD63高表达预示食管鳞癌预后不良
Yasunori Matsumoto,Ryota Otsuka,Yuri Nishioka et al.
Yasunori Matsumoto et al.
Introduction: Esophageal squamous cell carcinoma (ESCC) has one of the poorest cancer prognosis rates; there is an urgent need to develop new drug therapies and biomarkers. CD63, a tetraspanin protein and well-known exoso...
Post-Marketing Safety of Temozolomide: A Pharmacovigilance Study Based on the Food and Drug Administration Adverse Event Reporting System [0.03%]
基于美国食品药品监督管理局不良事件报告系统替莫唑胺上市后安全性的药物流行病学研究
Yuhao Lin,Muling Deng,Siqi Xu et al.
Yuhao Lin et al.
Introduction: Temozolomide (TMZ) is a widely used chemotherapy agent for the treatment of malignant gliomas and other brain tumors. Despite its established therapeutic benefits, there is an ongoing need to understand bett...